Cite
FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1.
MLA
Guo, Chaoqin, et al. “FGF19/FGFR4 Signaling Contributes to Hepatocellular Carcinoma Survival and Immune Escape by Regulating IGF2BP1-Mediated Expression of PD-L1.” Biomedicine & Pharmacotherapy, vol. 170, Jan. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biopha.2023.115955.
APA
Guo, C., Zhou, N., Lu, Y., Mu, M., Li, Z., Zhang, X., Tu, L., Du, J., Li, X., Huang, D., Xu, Q., & Zheng, X. (2024). FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1. Biomedicine & Pharmacotherapy, 170, N.PAG. https://doi.org/10.1016/j.biopha.2023.115955
Chicago
Guo, Chaoqin, Nana Zhou, Yisong Lu, Mingshan Mu, Zilin Li, Xu Zhang, Linglan Tu, et al. 2024. “FGF19/FGFR4 Signaling Contributes to Hepatocellular Carcinoma Survival and Immune Escape by Regulating IGF2BP1-Mediated Expression of PD-L1.” Biomedicine & Pharmacotherapy 170 (January): N.PAG. doi:10.1016/j.biopha.2023.115955.